Title | 1,2,3-Triazolylalkylribitol derivatives as nucleoside hydrolase inhibitors. |
Publication Type | Journal Article |
Year of Publication | 2007 |
Authors | Goeminne, A., M. McNaughton, G. Bal, G. Surpateanu, P. Van der Veken, S. De Prol, W. Versées, J. Steyaert, S. Apers, A. Haemers, and K. Augustyns |
Journal | Bioorg Med Chem Lett |
Volume | 17 |
Issue | 9 |
Pagination | 2523-6 |
Date Published | 2007 May 1 |
ISSN | 0960-894X |
Keywords | Animals, Chemistry, Pharmaceutical, Drug Design, Enzyme Inhibitors, Kinetics, Models, Chemical, Molecular Conformation, N-Glycosyl Hydrolases, Ribitol, Triazoles, Trypanosoma brucei brucei |
Abstract | A range of novel 1,2,3-triazolylalkylribitol derivatives were synthesized and evaluated as nucleoside hydrolase inhibitors. The most active compound (11a) has low micromolar potency and is structurally diverse from previously reported nucleoside hydrolase inhibitors, which, along with the simplicity of the chemistry involved in its synthesis, makes it a good lead for the further development of novel nucleoside hydrolase inhibitors. |
DOI | 10.1016/j.bmcl.2007.02.017 |
Alternate Journal | Bioorg. Med. Chem. Lett. |
PubMed ID | 17317181 |
- Log in to post comments
- Google Scholar
- PubMed
- DOI